Overview

Fluvastatin in the Therapy of Acute Coronary Syndrome

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
This study is to evaluate the safety and efficacy of fluvastatin versus placebo, dosed shortly after or immediately when the coronary event occurs.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Novartis
Collaborator:
Ministry of Health, Czech Republic
Treatments:
Fluvastatin
Criteria
Inclusion Criteria:

- Acute coronary syndrome

- Adults, 18 years and older

Exclusion Criteria:

- History of lipid lowering therapy less than 30 days before index event

- Pregnancy and nursing

- Subject younger than 18 years

Other inclusion and exclusion criteria may apply.